Depression usually has its onset during adolescence or early adulthood. Recurrences are common and contribute to its substantial disability. Mild symptoms may be the beginning of a new episode or lingering consequences of a partially remitted episode. Waiting for symptoms to become full blown or leaving mild symptoms untreated may miss opportunities to improve patient outcome. An understanding of the natural course of untreated depression, together with an appreciation of differences between clinical research and practice, facilitates translation of research findings into effective clinical care
Major depression is often a relapsing disorder. It is therefore important to start its treatment wit...
Objective: To examine the available scientific evidence for answers to clinically relevant questions...
Background: Controversy persists about how effectively empirically-supported treatments for major de...
Objective Reanalyse the patient-level data set of the Sequenced Treatment Alternatives to Relieve De...
In the past few decades substantial progress has been made in the research and development of treatm...
Depression has profound social, economic and personal consequences for the affected individual, and ...
Depression may affect up to 10\% of the population, with half of affected people having recurrence o...
PURPOSE OF REVIEW: Since the 70s, treatment of depression, especially pharmacologically, has expande...
PURPOSE OF REVIEW: Since the 70s, treatment of depression, especially pharmacologically, has expande...
Klein JP, Spaeth C, Schroeder J, et al. Time to remission from mild to moderate depressive symptoms:...
David Taylor, a consultant psychotherapist at the Tavistock & Portman NHS Foundation Trust (120 Bels...
In addition to a scoping review by Dr Rachelle Ashcroft and colleagues1 describing incentives and di...
Almost one in five individuals will experience a depressive disorder during their life. Apart from t...
Abstract The conceptualization and empirical knowledge base related to major depression has increase...
ObjectivesTo investigate whether the conclusion of a recent systematic review and network meta-analy...
Major depression is often a relapsing disorder. It is therefore important to start its treatment wit...
Objective: To examine the available scientific evidence for answers to clinically relevant questions...
Background: Controversy persists about how effectively empirically-supported treatments for major de...
Objective Reanalyse the patient-level data set of the Sequenced Treatment Alternatives to Relieve De...
In the past few decades substantial progress has been made in the research and development of treatm...
Depression has profound social, economic and personal consequences for the affected individual, and ...
Depression may affect up to 10\% of the population, with half of affected people having recurrence o...
PURPOSE OF REVIEW: Since the 70s, treatment of depression, especially pharmacologically, has expande...
PURPOSE OF REVIEW: Since the 70s, treatment of depression, especially pharmacologically, has expande...
Klein JP, Spaeth C, Schroeder J, et al. Time to remission from mild to moderate depressive symptoms:...
David Taylor, a consultant psychotherapist at the Tavistock & Portman NHS Foundation Trust (120 Bels...
In addition to a scoping review by Dr Rachelle Ashcroft and colleagues1 describing incentives and di...
Almost one in five individuals will experience a depressive disorder during their life. Apart from t...
Abstract The conceptualization and empirical knowledge base related to major depression has increase...
ObjectivesTo investigate whether the conclusion of a recent systematic review and network meta-analy...
Major depression is often a relapsing disorder. It is therefore important to start its treatment wit...
Objective: To examine the available scientific evidence for answers to clinically relevant questions...
Background: Controversy persists about how effectively empirically-supported treatments for major de...